Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
From Seedlings to Sustainability: Vita Coco Co-Founder on Eco‑Forward Path
Mike Kirban on how Vita Coco is shaping the future of beverages with sustainable sourcing, clean labeling and environmental impact tied to growth.
Mortgage Relief or Mirage? Where Rates Leave Homebuyers Today
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
Navigating Volatility: A Deep Dive into Today’s Supply Chain Trends
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
Inside the AI Bubble: Appian CEO Matt Calkins on Hype, Reality, and What’s Next
Appian CEO Matt Calkins explores where we are in the AI hype cycle, why enterprise adoption is lagging, and how regulation could reshape the future.
Innovation in the Skies: Inside Delta’s Green Tech Journey
Delta CSO Amelia DeLuca reveals at the Fast Co. Innovation Festival how tech, sustainable aviation fuel, and smart operations are revolutionizing air travel.
Nvidia to invest $100 billion in OpenAI to help expand the ChatGPT maker’s computing power
Chipmaker Nvidia will invest $100 billion in OpenAI as part of a partnership that will add at least 10 gigawatts of Nvidia AI data centers to ramp up the computing power for the owner of the artificial intelligence chatbot ChatGPT.
Rivals Compass and Anywhere Real Estate to combine under one umbrella
Two of the nation’s biggest real estate services companies are combining in a deal that will bring Century 21, Compass and several other major brokerage brands under the same umbrella.
Using ICE’s Futures and Options Markets to Manage Risk
Chris Rhodes, President of ICE Futures Europe, discusses the current energy and interest rate landscapes.
